S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.02%) 15 928 points
Oil
(-0.81%) $83.17
Gas
(0.99%) $1.942
Gold
(-0.39%) $2 338.10
Silver
(0.02%) $27.54
Platinum
(0.72%) $928.70
USD/EUR
(-0.16%) $0.933
USD/NOK
(-0.12%) $11.01
USD/GBP
(-0.22%) $0.799
USD/RUB
(0.25%) $92.11

リアルタイムの更新: BioCorRx Inc. [BICX]

取引所: PNK 産業: Medical Care Facilities
最終更新日時27 4月 2024 @ 00:36

-8.54% $ 0.750

Live Chart Being Loaded With Signals

Commentary (27 4月 2024 @ 00:36):

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition...

Stats
本日の出来高 902.00
平均出来高 1 055.00
時価総額 6.61M
EPS $0 ( 2024-04-01 )
次の収益日 ( $0 ) 2024-05-12
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -1.670
ATR14 $0 (0.00%)
Insider Trading
Date Person Action Amount type
2024-03-28 Galligan Joseph J Buy 5 566 Common Stock, par value $0.001
2024-01-02 Galligan Joseph J Buy 6 173 Common Stock, par value $0.001
2024-03-28 Granier Brady James Buy 16 698 Stock Option
2024-03-28 Murthy Harsha Buy 5 566 Common Stock, par value $0.001
2024-01-02 Murthy Harsha Buy 6 173 Common Stock, par value $0.001
INSIDER POWER
100.00
Last 98 transactions
Buy: 888 470 | Sell: 0

BioCorRx Inc. 相関

10 最も正の相関
10 最も負の相関

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

BioCorRx Inc. 財務諸表

Annual 2023
収益: $89 160.00
総利益: $-146 762 (-164.61 %)
EPS: $-0.450
FY 2023
収益: $89 160.00
総利益: $-146 762 (-164.61 %)
EPS: $-0.450
FY 2022
収益: $213 841
総利益: $198 562 (92.85 %)
EPS: $-0.610
FY 2021
収益: $48 272.00
総利益: $42 391.00 (87.82 %)
EPS: $-0.810

Financial Reports:

No articles found.

BioCorRx Inc.

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。